Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks ...

Roche ( OTCQX:RHHBY ) unit Genentech announces  encouraging data from early-stage studies of two investigational T-cell engaging bispecific antibodies, mosunetuzumab and CD20-TCB, in treatment-resistant non-Hodgkin lymphoma (NHL) patients, including some who failed to respond to CAR T ...

A number of biotech companies are awaiting responses from the U.S. Food and Drug Administration (FDA) this month. If granted approval from the agency, it wouldn't be surprising if many of these stocks see a big jump following the news. While many drug candidates will receive a response from t...